Офтальмологические изменения у пациентов, перенесших COVID-19 ассоциированную пневмонию

Abstract

Definition of COVID-19 (CoronaVirusDesease 2019) is a severe acute respiratory infection caused by the SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2). On March 11, 2020, WHO announced the beginning of the COVID-19 pandemic. According to Rospotrebnadzor in Russia, the disease is asymptomatic in 23% of patients, 63% have manifestations of acute upper respiratory tract infection, and 14% pneumonia occurs. The average mortality rate in the world is about 3%. The first cases of the disease were reported in Wuhan (Hubei province, in the southeast of China) in December 2019.Despite the measures taken to prevent the spread of the new infection, in February the epidemic covered many countries, including Italy, South Korea, Iran, and in March it turned into a pandemic. Objective: to identify ophthalmological changes in patients who have had COVID-19 associated pneumonia. Materials and methods: 153 patients over 18 years of age with a confirmed diagnosis of COVID-19 associated pneumonia were examined 3 months after discharge from the hospital. Results and discussion: 7.84% – chronic blepharitis, 5.88% – chronic conjunctivitis, 60.0% – dry eye syndrome, 5.8% – degenerative conjunctival changes (5.88%) and 100% changes in conjunctival hemodynamics characteristic of hypercoagulation syndrome. Conclusions: in all cases of observation, a violation of hemodynamic changes in the conjunctiva was detected.